The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/11585753

Cancer Res. 2001 Oct 1 61 19 7184-8

Download in:

View as

General Info

PMID
11585753